Primary Liver Cancer Clinical Trial
Official title:
Chinese Liver Cancer Clinical Survey
In order to make better use of clinical resources of the real world, strengthen the standardization of PLC diagnosis and treatment, and constantly improve the academic level of liver cancer in China, we intends to launch "Chinese Liver Cancer clinical Survey" project in cancer specialized hospitals and large general hospitals and to explore the best clinical pathway of PLC multidisciplinary consultation.
Primary liver cancer (PLC) is one of the most common malignant tumors of digestive system and also a serious threat to the health and safety of Chinese people, and has caused serious economic burden to the country. Research purposes: To understand the clinical characteristics of patients with primary liver cancer (PLC) in China; To investigate the etiology and pathogenesis of PLC in China; To understand the current status of clinical treatment of PLC in China, and to analyze the gaps among these conditions and domestic treatment guidelines, industry consensus, the international treatment guidelines; To understand the different treatment options and its clinical outcomes, and to explore the best treatment options; To explore the best clinical pathway of PLC multidisciplinary consultation; To provide the basis for the development of clinical guidelines for PLC in China. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00261378 -
Prospective Randomised Study of Doxorubicin in the Treatment of Hepatocellular Carcinoma by Drug-Eluting Bead Embolisation
|
Phase 2 | |
| Enrolling by invitation |
NCT05609448 -
MRI-guided Holmium-166 Radioembolization
|
N/A | |
| Recruiting |
NCT05714124 -
Liver Embolization Approaches for Tumor Management
|
||
| Not yet recruiting |
NCT05353894 -
Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GNS561 After One Single Dose (50 and 200mg) in Healthy Volunteers
|
Phase 1 | |
| Completed |
NCT03518632 -
Preoperative Physical Activity Intervention in Patients Before Planned Liver Resection for Cancer (APACHE)
|
N/A | |
| Terminated |
NCT00003530 -
Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
|
Phase 2 | |
| Recruiting |
NCT04806464 -
Clinical Study of VG161 in Subjects With Advanced Primary Liver Cancer
|
Phase 1 | |
| Recruiting |
NCT06342414 -
An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer
|
||
| Completed |
NCT01116804 -
Role PET Imaging in Response Assessment for Hepatocellular Carcinoma (HCC)
|
Phase 1 | |
| Recruiting |
NCT03067493 -
RFA or Surgical Resection Combined With Neo-MASCT for Primary HCC: a Phase II Trial
|
Phase 2 | |
| Completed |
NCT05183776 -
Clinical Validation of a Fractional Administration Device for Holmium-166 SIRT
|
N/A | |
| Not yet recruiting |
NCT06430983 -
Recurrent Liver Cancer: Reconceptualization and Reevaluation
|
||
| Recruiting |
NCT05677724 -
Single-cell RNA Sequencing Resolves the Regulatory Role of HBV on the Hepatocellular Carcinoma Immune Microenvironment
|
||
| Not yet recruiting |
NCT03178929 -
Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma
|
N/A | |
| Recruiting |
NCT05267080 -
Registry on Percutaneous Electrochemotherapy
|
||
| Not yet recruiting |
NCT02327819 -
The Effect of Branched-chain Amino Acid (BCAA) on the Progression of Primary Liver Cancer
|
N/A | |
| Completed |
NCT01640522 -
Comprehensive Electronic Cancer Support System for the Treatment of Cancer Related Symptoms
|
N/A | |
| Completed |
NCT00408122 -
Evaluation of Preoperative Investigations in Patients With Liver Cancer
|
N/A | |
| Recruiting |
NCT03297255 -
Primary Liver Cancer Cohort of South China
|
N/A | |
| Recruiting |
NCT06325267 -
Clinical Characteristics of Primary Liver Cancer
|